| abstract |
[PROBLEMS] To provide a safe drug that simultaneously realizes (1) lowering of blood homocysteine level, (2) enhancement of the activity of nitrogen monoxide synthase of vascular endothelial cells and/or increase of blood nitrogen monoxide level ascribed to vascular endothelial cells and (3) enhancement of the activity of glutathione peroxidase. [MEANS FOR SOLVING PROBLEMS] There is provided a pharmaceutical composition comprising an HMG-CoA reductase inhibitor and glutathione. |